Assessment of risk factors for 30-Day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma

Janelle M. Fauci, Kellie E. Schneider, Peter J. Frederick, Gregory Wilding, Joe Consiglio, Amelia L. Sutton, Larry Kilgore, Mack N. Barnes

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

To evaluate factors that place epithelial ovarian cancer (EOC) patients at increased risk for hospital readmission. Methods: A retrospective review of patients diagnosed with EOC undergoing surgical cytoreduction at the University of Alabama at Birmingham from 2001 to 2008 was performed. Patients who required readmission were identified. Demographic data, comorbidities, surgical data including bowel resections, and hospital length of stay were evaluated. Results: A total of 207 patients were identified. The mean age at diagnosis was 64 years (range, 32Y89 years), 58% had optimal debulking (n = 120), and the mean number of comorbidities was 1.3 (range, 0Y6). Readmission within 30 days of discharge occurred in 33 (16%) of 207 patients. The readmission group had a statistically higher number of comorbidities (1.75 vs 1.01, P = 0.025). The most common reasons for readmission were small bowel obstruction/ileus, wound complications, and thromboembolic events. Conclusions: The most common reason for readmission after cytoreductive surgery for EOC is small bowel obstruction/ileus. Studies assessing postoperative disease management programs including nursing telephone follow-up, administration of outpatient intravenous fluids, and continuation of antithrombotic agents may offer opportunities to reduce readmissions.

Original languageEnglish (US)
Pages (from-to)806-810
Number of pages5
JournalInternational Journal of Gynecological Cancer
Volume21
Issue number5
DOIs
StatePublished - Jun 1 2011

Fingerprint

Patient Readmission
Carcinoma
Comorbidity
Ileus
Length of Stay
Fibrinolytic Agents
Disease Management
Telephone
Intravenous Administration
Nursing
Outpatients
Demography
Wounds and Injuries
Ovarian epithelial cancer

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynecology

Cite this

Fauci, J. M., Schneider, K. E., Frederick, P. J., Wilding, G., Consiglio, J., Sutton, A. L., ... Barnes, M. N. (2011). Assessment of risk factors for 30-Day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma. International Journal of Gynecological Cancer, 21(5), 806-810. https://doi.org/10.1097/IGC.0b013e3182157a19

Assessment of risk factors for 30-Day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma. / Fauci, Janelle M.; Schneider, Kellie E.; Frederick, Peter J.; Wilding, Gregory; Consiglio, Joe; Sutton, Amelia L.; Kilgore, Larry; Barnes, Mack N.

In: International Journal of Gynecological Cancer, Vol. 21, No. 5, 01.06.2011, p. 806-810.

Research output: Contribution to journalArticle

Fauci, Janelle M. ; Schneider, Kellie E. ; Frederick, Peter J. ; Wilding, Gregory ; Consiglio, Joe ; Sutton, Amelia L. ; Kilgore, Larry ; Barnes, Mack N. / Assessment of risk factors for 30-Day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma. In: International Journal of Gynecological Cancer. 2011 ; Vol. 21, No. 5. pp. 806-810.
@article{09509618a0ed43e0874fb5a10786b8a2,
title = "Assessment of risk factors for 30-Day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma",
abstract = "To evaluate factors that place epithelial ovarian cancer (EOC) patients at increased risk for hospital readmission. Methods: A retrospective review of patients diagnosed with EOC undergoing surgical cytoreduction at the University of Alabama at Birmingham from 2001 to 2008 was performed. Patients who required readmission were identified. Demographic data, comorbidities, surgical data including bowel resections, and hospital length of stay were evaluated. Results: A total of 207 patients were identified. The mean age at diagnosis was 64 years (range, 32Y89 years), 58{\%} had optimal debulking (n = 120), and the mean number of comorbidities was 1.3 (range, 0Y6). Readmission within 30 days of discharge occurred in 33 (16{\%}) of 207 patients. The readmission group had a statistically higher number of comorbidities (1.75 vs 1.01, P = 0.025). The most common reasons for readmission were small bowel obstruction/ileus, wound complications, and thromboembolic events. Conclusions: The most common reason for readmission after cytoreductive surgery for EOC is small bowel obstruction/ileus. Studies assessing postoperative disease management programs including nursing telephone follow-up, administration of outpatient intravenous fluids, and continuation of antithrombotic agents may offer opportunities to reduce readmissions.",
author = "Fauci, {Janelle M.} and Schneider, {Kellie E.} and Frederick, {Peter J.} and Gregory Wilding and Joe Consiglio and Sutton, {Amelia L.} and Larry Kilgore and Barnes, {Mack N.}",
year = "2011",
month = "6",
day = "1",
doi = "10.1097/IGC.0b013e3182157a19",
language = "English (US)",
volume = "21",
pages = "806--810",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Assessment of risk factors for 30-Day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma

AU - Fauci, Janelle M.

AU - Schneider, Kellie E.

AU - Frederick, Peter J.

AU - Wilding, Gregory

AU - Consiglio, Joe

AU - Sutton, Amelia L.

AU - Kilgore, Larry

AU - Barnes, Mack N.

PY - 2011/6/1

Y1 - 2011/6/1

N2 - To evaluate factors that place epithelial ovarian cancer (EOC) patients at increased risk for hospital readmission. Methods: A retrospective review of patients diagnosed with EOC undergoing surgical cytoreduction at the University of Alabama at Birmingham from 2001 to 2008 was performed. Patients who required readmission were identified. Demographic data, comorbidities, surgical data including bowel resections, and hospital length of stay were evaluated. Results: A total of 207 patients were identified. The mean age at diagnosis was 64 years (range, 32Y89 years), 58% had optimal debulking (n = 120), and the mean number of comorbidities was 1.3 (range, 0Y6). Readmission within 30 days of discharge occurred in 33 (16%) of 207 patients. The readmission group had a statistically higher number of comorbidities (1.75 vs 1.01, P = 0.025). The most common reasons for readmission were small bowel obstruction/ileus, wound complications, and thromboembolic events. Conclusions: The most common reason for readmission after cytoreductive surgery for EOC is small bowel obstruction/ileus. Studies assessing postoperative disease management programs including nursing telephone follow-up, administration of outpatient intravenous fluids, and continuation of antithrombotic agents may offer opportunities to reduce readmissions.

AB - To evaluate factors that place epithelial ovarian cancer (EOC) patients at increased risk for hospital readmission. Methods: A retrospective review of patients diagnosed with EOC undergoing surgical cytoreduction at the University of Alabama at Birmingham from 2001 to 2008 was performed. Patients who required readmission were identified. Demographic data, comorbidities, surgical data including bowel resections, and hospital length of stay were evaluated. Results: A total of 207 patients were identified. The mean age at diagnosis was 64 years (range, 32Y89 years), 58% had optimal debulking (n = 120), and the mean number of comorbidities was 1.3 (range, 0Y6). Readmission within 30 days of discharge occurred in 33 (16%) of 207 patients. The readmission group had a statistically higher number of comorbidities (1.75 vs 1.01, P = 0.025). The most common reasons for readmission were small bowel obstruction/ileus, wound complications, and thromboembolic events. Conclusions: The most common reason for readmission after cytoreductive surgery for EOC is small bowel obstruction/ileus. Studies assessing postoperative disease management programs including nursing telephone follow-up, administration of outpatient intravenous fluids, and continuation of antithrombotic agents may offer opportunities to reduce readmissions.

UR - http://www.scopus.com/inward/record.url?scp=82955186882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955186882&partnerID=8YFLogxK

U2 - 10.1097/IGC.0b013e3182157a19

DO - 10.1097/IGC.0b013e3182157a19

M3 - Article

VL - 21

SP - 806

EP - 810

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 5

ER -